As a key device in the modern medical system for achieving intravenous infusion, intravenous drug delivery devices play a vital role in the precise, safe, and continuous delivery of drugs, nutritional solutions, and other therapeutic fluids into the human body. Their applications span all scenarios, including emergency resuscitation, perioperative management, chronic disease maintenance therapy, and intensive care. They serve as a core bridge connecting drugs to the body's circulation, and their technological level and functional completeness directly affect treatment outcomes and patient safety.
From a basic functional perspective, the core of intravenous drug delivery devices is to establish a stable intravenous access and utilize gravity or power to achieve controlled fluid infusion. Traditional intravenous infusion devices, represented by gravity-fed infusion sets, rely on hydrostatic pressure created by the difference in fluid level. They are simple in structure, cost-effective, and suitable for routine fluid replacement and drug infusion. However, with the increasing specialization of clinical needs, power-driven devices (such as peristaltic pumps and syringe pumps), with their precise flow rate control capabilities, have become essential equipment for micro-drug infusions (such as vasoactive drugs and chemotherapy drugs) and for the treatment of special populations (such as newborns and critically ill patients). These devices can control infusion errors to a very low range, avoiding risks caused by dosage deviations.
From a structural design perspective, intravenous drug delivery devices have formed a modular and functionally integrated technical system. Basic components include infusion tubing, a puncture needle (or indwelling catheter connector), a drip chamber, a regulator, and a filter. The filter's precision (e.g., 0.2μm, 1.2μm) can be selected according to the drug's characteristics, effectively intercepting particles, microorganisms, or sensitizing substances. Advanced devices integrate anti-backflow valves, drip rate monitoring modules, and bubble detection sensors. The former prevents blood reflux from clogging the tubing or causing infection, while the latter improves infusion safety through real-time monitoring. Furthermore, to address the irritation caused by specific drugs (such as high-concentration electrolytes and chemotherapy drugs), the selection of materials for these devices prioritizes biocompatibility, employing low-dissolution and low-adsorption polymers to minimize damage to the vascular endothelium.
From an application perspective, the adaptability of intravenous drug delivery devices continues to expand with clinical needs. In general wards, disposable gravity infusion sets remain the mainstream due to their ease of operation; ICUs and operating rooms rely on the multi-channel independent control function of infusion pumps to meet the needs of simultaneous multi-drug infusion and rapid dose adjustment; in tumor treatment, light-protected infusion sets prevent the degradation of photosensitizing drugs; and in pediatric and geriatric patient care, narrow-bore, low-flow-rate devices reduce the risk of vascular injury. Of particular note is the gradual emergence of intelligent intravenous drug delivery systems, which utilize IoT technology to achieve remote monitoring of infusion parameters, abnormal warnings, and data traceability, providing new tools for precision medicine and nursing quality control.
As the core carrier of intravenous therapy, the development of intravenous drug delivery devices has always been guided by the principles of "safety, precision, and adaptability." In the future, with the advancement of minimally invasive interventional technology, intelligent sensing, and biomaterials science, breakthroughs will continue to be made in infusion accuracy, complication prevention, and optimization of patient comfort, further solidifying its fundamental support role in clinical treatment and health management.